SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test
Introduction to the Test
The SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test is an advanced diagnostic tool designed to detect mutations in the SMN1 gene, which are responsible for spinal muscular atrophy (SMA) type 2. This test is crucial for early diagnosis, enabling timely intervention and management of this debilitating neurological disorder.
What the Test Measures
This genetic test employs Next Generation Sequencing (NGS) technology to analyze the SMN1 gene, identifying any mutations that may lead to the development of SMA type 2. By pinpointing these genetic alterations, healthcare providers can make informed decisions regarding treatment and management strategies.
Who Should Consider This Test?
Individuals who may benefit from the SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test include:
- Those exhibiting symptoms of spinal muscular atrophy, such as muscle weakness and atrophy.
- Individuals with a family history of SMA, particularly if there are known cases within the family.
- Patients referred by a neurologist or geneticist for further evaluation of suspected SMA.
Benefits of Taking the Test
The advantages of undergoing the SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test include:
- Early diagnosis of SMA type 2, leading to timely intervention.
- Informed decision-making regarding treatment options and management strategies.
- Enhanced understanding of family risk and potential genetic counseling opportunities.
- Peace of mind through definitive genetic testing.
Understanding Your Results
Upon completion of the test, results will be provided along with a detailed explanation of what they mean. It is essential to discuss these results with a healthcare provider, who can guide you through the implications and next steps based on the findings.
Test Details and Pricing
| Test Name | Discount Price (NGN) | Regular Price (NGN) |
|---|---|---|
| SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking Your Test
To schedule your SMN1 Gene Spinal Muscular Atrophy Type 2 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and any questions you may have.
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test can be blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a genetic counseling session is recommended to draw a pedigree chart of family members affected with SMA.
For a comprehensive evaluation, consult with a neurologist or geneticist who can provide guidance tailored to your specific situation.
